Broadwood Partners, L.P. Buys 23,000 Shares of STAAR Surgical (NASDAQ:STAA) Stock

STAAR Surgical (NASDAQ:STAA) major shareholder Broadwood Partners, L.P. bought 23,000 shares of the business’s stock in a transaction that occurred on Wednesday, December 18th. The stock was purchased at an average cost of $24.33 per share, for a total transaction of $559,590.00. Following the completion of the transaction, the insider now directly owns 10,848,631 shares in the company, valued at approximately $263,947,192.23. This trade represents a 0.21 % increase in their position. The acquisition was disclosed in a document filed with the Securities & Exchange Commission, which is accessible through this hyperlink. Major shareholders that own more than 10% of a company’s stock are required to disclose their sales and purchases with the SEC.

Broadwood Partners, L.P. also recently made the following trade(s):

• On Monday, December 16th, Broadwood Partners, L.P. purchased 53,500 shares of STAAR Surgical stock. The shares were purchased at an average price of $24.24 per share, with a total value of $1,296,840.00.

STAAR Surgical Stock Up 3.0 %

STAA opened at $24.98 on Friday. The firm’s 50 day moving average is $28.31 and its 200-day moving average is $34.56. STAAR Surgical has a 52-week low of $23.72 and a 52-week high of $52.68. The firm has a market capitalization of $1.23 billion, a P/E ratio of 56.77 and a beta of 0.59.

Institutional Investors Weigh In On STAAR Surgical

Hedge funds and other institutional investors have recently added to or reduced their stakes in the company. Mutual of America Capital Management LLC boosted its position in STAAR Surgical by 214.7% in the 2nd quarter. Mutual of America Capital Management LLC now owns 26,459 shares of the medical instruments supplier’s stock valued at $1,260,000 after buying an additional 18,051 shares during the last quarter. ClariVest Asset Management LLC purchased a new position in STAAR Surgical in the second quarter valued at about $1,223,000. Algert Global LLC grew its stake in STAAR Surgical by 13.5% during the 2nd quarter. Algert Global LLC now owns 116,655 shares of the medical instruments supplier’s stock valued at $5,554,000 after purchasing an additional 13,901 shares in the last quarter. Granite Investment Partners LLC acquired a new stake in STAAR Surgical during the 2nd quarter valued at approximately $17,237,000. Finally, Polar Asset Management Partners Inc. increased its holdings in STAAR Surgical by 44.3% during the 3rd quarter. Polar Asset Management Partners Inc. now owns 168,800 shares of the medical instruments supplier’s stock worth $6,271,000 after purchasing an additional 51,800 shares during the last quarter. Hedge funds and other institutional investors own 96.70% of the company’s stock.

Wall Street Analysts Forecast Growth

STAA has been the subject of a number of research reports. Stephens upgraded STAAR Surgical to a “hold” rating in a report on Monday, December 2nd. Needham & Company LLC reiterated a “hold” rating on shares of STAAR Surgical in a research note on Thursday, October 31st. Canaccord Genuity Group cut their target price on shares of STAAR Surgical from $31.00 to $28.00 and set a “hold” rating on the stock in a research note on Monday, December 9th. Finally, Stifel Nicolaus reduced their target price on shares of STAAR Surgical from $50.00 to $44.00 and set a “buy” rating on the stock in a report on Monday, August 26th. One research analyst has rated the stock with a sell rating, four have given a hold rating and four have issued a buy rating to the company. Based on data from MarketBeat.com, STAAR Surgical has an average rating of “Hold” and a consensus price target of $42.83.

STAAR Surgical Company Profile

STAAR Surgical Company, together with its subsidiaries, designs, develops, manufactures, markets, and sells implantable lenses for the eye, and companion delivery systems to deliver the lenses into the eye. The company provides implantable Collamer lens product family (ICLs) to treat visual disorders, such as myopia, hyperopia, astigmatism, and presbyopia.